Jelena Ivanovic (#AIFA) eletta Co-Chair del sottogruppo UE sulle tecnologie sanitarie emergenti.
Un ruolo chiave nel sistema europeo di #HTA e strategico per accelerare #innovazione e accesso ai #farmaci per i #pazienti.
👉 www.aifa.gov.it/-/jelena-iva...
Text: ISPOR: May 17 - 20, 2026 | Philadelphia, USA. Lumanity is going to ISPOR 2026! Meet the team at booth #624. Lumanity logo.
Heading to ISPOR 2026 in Philadelphia this May? We are too!
The Lumanity team will be on-site at booth #624, ready to help you navigate evolving policy shifts, shape compelling value stories, and share insights.
Find out more on our website: lumanity.com/events/ispor...
#ISPOR2026 #HEOR #RWE #HTA
v0.16.3 of the #rstats #eq5d package is now on #CRAN. The release includes the new EQ-5D-5L value set for UK and the EQ-5D-Y-3L value set for Hong Kong.
More info and examples of how to use it at github.com/fragla/eq5d and cran.r-project.org/package=eq5d.
@euroqol.bsky.social
#heor #hta
Across many countries, the question is no longer whether health policy should be evidence-informed—but how to make it happen in practice.🤝
📰Great to join the Health Economic Analysis for Evidence-Driven Health Policies workshop in Colombo (3–4 Mar).
#HTA #HealthEconomics #SriLanka
Graphic in white and pink. There is a headshot of Andria Joseph. The quoted text reads: "It is exciting to see the publication of the new UK EQ-5D-5L value set in Value in Health. For those working across HEOR, HTA and market access, this is a significant development for the UK evidence landscape. For HEOR, this matters because the choice of value set can directly influence utility estimates, QALY calculations and, ultimately, the results of economic evaluations." Andria Joseph, Project Director. The YHEC 40th anniversary logo also features
It is great to see the publication of the new UK EQ-5D-5L value set in Value in Health. For those working across HEOR, HTA and market access, this is an important development for the UK evidence landscape.
Want to discuss what this means? Get in touch: www.yhec.co.uk/contact-us/
#HEOR #HTA #EQ5D
Our March 2026 newsletter is out, featuring work on anaemia target-setting, genomics and equity in HTA.
Plus seminars from global leaders, short courses, and opportunities to get involved.
👉 Read more: cm.edm.unimelb.edu.au/t/r-e-tkkiyh...
#HealthEconomics #HTA #Equity #GlobalHealth
#CancerAdvocacy #PatientVoices #HTA #tarlatamab #PatientExperience #CancerSupport #Imdelltra #SmallCellLungCancer #SCLC #PatientAdvocacy #CaregiverSupport #CancerAwareness #PublicFunding #AccessToCare #LungCancerCanada
Turn complex decision models into actionable insights 📊
Our Decision Modelling Foundation short course with @york.ac.uk will teach you to build, analyse, and apply models in Excel or R for real-world #HealthEconomics decisions #HTA
Learn more ▶️ modelling.he-evalcourses.com
HealthTech Bridge: Pioneering International HealthTech Entry into U.S. Market #United_States #Fayetteville #HealthTech_Bridge #Venture_Atlas_Labs #HTA
From policy to practice: what comes next for #HTA, #EHDS, and digital health in Europe?
A new #EDiHTA article looks at how evolving EU frameworks can support the assessment of digital health technologies and strengthen patient involvement in decision-making.
🔗 edihta-project.eu/bridging-pol...
Andy Briggs & Francis Ruiz unpack the UK government’s (non-)response to opposition over proposals allowing ministers to direct @nicecomms.bsky.social on its cost-effectiveness threshold.
open.substack.com/pub/occamres...
#healtheconomics #qaly #economicevaluation #HTA
Shape the future of #HealthEconomics 🌍
Whether you’re an #HTA analyst, researcher, or consultant, our Decision Modelling courses help you build practical skills for cost-effectiveness #evaluation
Ideal for:
💊 Pharma
📊 Consultancy
🎓 Academia
🏥 Health services
Apply ▶️ modelling.he-evalcourses.com
TOMORROW --> From cancer screening to infectious disease, decision-analytic modeling drives the evidence behind clinical guidelines and HTA worldwide. Register here: buff.ly/nNtdPnY #SMDM #MedicalDecisionMaking #HTA
From cancer screening to infectious disease, decision-analytic modeling drives the evidence behind clinical guidelines and HTA worldwide. Build your foundational skills in this introductory course led by two of the field's leading faculty. #SMDM #MedicalDecisionMaking #HTA
Your guide to the World Evidence, Pricing and Access Congress 2026: Key sessions on pricing, EU HTA, innovation and sustainability becarispublishing.com/digital-cont... #WorldEPACongress #MarketAccess #HTA
📢 Webinar: EDiHTA Open Call for DHT Developers / Manufacturers
🗓 12 March 2026 | 16:00 CET
Learn about eligibility, timelines & piloting of the first pan-European DHTA framework. Live Q&A with the team.
🔗 Register: events.teams.microsoft.com/event/f37135...
#EDiHTA #DigitalHealth #HTA
I'm excited to speak at #NICEConf26, joining friends and colleagues Nick Crabb, Nicole Mittmann, and Mark Sculpher! More information available at: bit.ly/4iApctH, and you can register at: bit.ly/49PQxGd
@nicecomms.bsky.social @icer-review.bsky.social #HTA
Patient registries show how treatments work over time and what truly matters to patients. To use registry data in regulatory and #HTA decisions, we need clear standards and patient trust.
Input on use of registry data in health decisions
👉 Take the survey-https://bit.ly/4kUh0G3
📍The reference case, methodology review, and systematic review/meta-analysis papers are all available at the link below:
🔗https://bit.ly/4s51t8I
🔗https://bit.ly/4rPSBEp
🔗https://bit.ly/3ZQvbSW
#HTA #EarlyHTA #PrecisionMedicine #HealthEconomics #LMICs #CostEffectiveness #EconomicEvaluation
As if that will stop him. 😂
He’s got stolen oil money in Qatar, bitcoins going to ?, gave 40B to Argentina bc ?.
@chrismurphyct.bsky.social you are a great person and trying to hold people accountable. Problem is GOP needs to ACT! WHY does it ALWAYS have to be Dems & Massie w your hands tied? #HTA
📢 The EHC Public Policy Review (PPR) is out! Covering #EUHealthPolicy developments from Jan 2025 to Jan 2026, it breaks down what matters most for the #BleedingDisorders community — pharma reform, #EHDS, #HTA, #CriticalMedicinesAct, EU Biotech Act & social care. 📖 buff.ly/vIIDSak
🤝 50 stakeholders gathered in Brussels for the #EDiHTA Co-Creation & Evaluation Workshop to validate the draft framework for Digital Health Technologies.
📸 Read more & see photos: edihta-project.eu/stakeholders...
#EDiHTA #HTA #DigitalHealth #EUHealth #HealthPolicy #CoCreation #EUProjects
New paper w/Paul Martin & Jin Ding: “Why is the pharmaceutical industry investing in targeted therapies? The emergence of “premium pharma" | How #orphandrugs #ATMPs #TargetedTherapies reshape #BioPharmaInnovation #HTA sciencedirect.com/science/article/pii/S0277953625012195 @sheffielduni.bsky.social
🎥 How can Europe assess digital health technologies in a consistent and evidence-based way?
In our new video, Cheri Mathiasen from Odense University Hospital explains how EDiHTA is co-creating a European assessment model for DHTs.
youtu.be/I_z9Dd-Mu0E
#EDiHTA #DigitalHealth #HTA #HorizonEurope
On the left of the graphic are two images of a presenter and audience at a conference. On the right side of the image, the WEPA logo is overlayed with the text: "We're exhibiting. World EPA Congress. 3 to 4 March 2026. RAI Convention Centre, Amsterdam. Join us. Europe's largest congress in market access, pricing and evidence"
Heading to Amsterdam for the World Evidence, Pricing and Access (WEPA) Congress 2026? ✈️
It’s set to be a busy two days of discussing the latest in HTA, market access strategy and the evolving role of real-world evidence.
To speak with us, visit Booth 600.
#WorldEPACongress #MarketAccess #HTA
The Beneluxa Initiative identified impactful medicines suitable for joint #HTA submission or combined with a joint negotiation to three or more countries within Beneluxa.
Interested? 👉 The list of medicines is available on the Beneluxa website: beneluxa.org/node/19
Kudos to @htaiorg.bsky.social and the Patient and Citizen Involvement group (PCIG), book editors and the many contributors. This is quite the comprehensive volume on #HTA with many global perspectives.
#patientengagement
#healthtechnologyassessment
#globalhealth
Hot off the press: Part one of our pick of articles within #HTA and #RWE published in January 2026 | Becaris Publishing becarispublishing.com/digital-cont...
How are treatment decisions made in Europe? And how can YOUR voice shape them? Understanding #HTA gives patients real power in shaping treatment access.
Join this @ec.europa.eu webinar to learn how YOU can participate in consultations.
🔗http://bit.ly/3MoMV4z
